P&G Hygiene and Health Care Ltd (PGHH) has announced its unaudited financial results for the quarter ended September 30, 2025, revealing the company's performance in its two main segments: Health Care Products and Hygiene Products.

Financial Results Overview

The Board of Directors approved the results at a meeting held on November 6, 2025. Key financial highlights include:

Segment Operations

PGHH operates in two main segments:

1. Health Care Products: Comprising ointments, creams, cough drops, and tablets
2. Hygiene Products: Including feminine hygiene products and other skin care hygiene items

Financial Position

As of September 30, 2025, PGHH's financial position remains strong:

• Cash and Cash Equivalents: ₹782.10 crore
• Total Assets: ₹2,133.41 crore
• Total Equity: ₹931.27 crore

Audit and Review

The financial results were reviewed by the Audit Committee and have been subject to limited review by statutory auditors.

Change in Financial Year

The company changed its financial year from June 30 to March 31, with the previous financial year 2024-25 covering nine months from July 1, 2024, to March 31, 2025.

Investors and stakeholders may closely monitor how PGHH navigates market conditions in the coming quarters, balancing revenue growth with profitability and operational efficiency across its key product categories.

P&G Hygiene and Health Care has announced a crucial board meeting scheduled for February 11, 2025, to discuss and potentially approve key financial matters. The company, a prominent player in the hygiene and health care sector, will be reviewing its unaudited financial results for the quarter ending December 31, 2024.

Financial Results and Dividend Consideration

The board meeting agenda includes:

1. Consideration of the company's financial performance for the third quarter of the fiscal year 2024-25.
2. Deliberation on the declaration of an interim dividend for the financial year 2024-25.

This review is a standard practice for publicly traded companies and provides investors and stakeholders with insights into the company's recent financial health and operational performance.

Record Date for Potential Dividend

Should the board approve the interim dividend, P&G Hygiene has set February 20, 2025, as the record date. This date determines which shareholders are eligible to receive the dividend payment, if declared.

Recent Corporate Governance Developments

In its 61st Annual General Meeting held on September 4, 2025, the company's shareholders approved several key resolutions:

1. Re-appointment of Mr. Chittranjan Dua as a Non-Executive Independent Director for a five-year term, effective August 25, 2025.
2. Re-appointment of Mr. Krishnamurthy Iyer as a Non-Executive Independent Director for a five-year term, effective December 1, 2025.
3. Appointment of M/s. M K Saraf & Associates LLP as secretarial auditors for a five-year period.

These appointments reflect the company's commitment to maintaining strong corporate governance practices and ensuring continuity in its board structure.

Financial Performance Context

In its 61st Annual General Meeting presentation, P&G Hygiene reported:

These figures compare the fiscal year 2024-25 (a 9-month period due to a change in the financial year) to the equivalent period in the previous year.

The upcoming board meeting and potential dividend declaration will be closely watched by investors as indicators of the company's current financial health and future outlook in the competitive hygiene and health care market.